These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37277619)

  • 1. Medical Care Use Among Patients with Monogenic Osteoporosis Due to Rare Variants in LRP5, PLS3, or WNT1.
    Verdonk SJE; Storoni S; Zhytnik L; Zhong W; Pals G; van Royen BJ; Elting MW; Maugeri A; Eekhoff EMW; Micha D
    Calcif Tissue Int; 2023 Aug; 113(2):186-194. PubMed ID: 37277619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders.
    Oheim R; Tsourdi E; Seefried L; Beller G; Schubach M; Vettorazzi E; Stürznickel J; Rolvien T; Ehmke N; Delsmann A; Genest F; Krüger U; Zemojtel T; Barvencik F; Schinke T; Jakob F; Hofbauer LC; Mundlos S; Kornak U
    J Clin Endocrinol Metab; 2022 Jun; 107(7):e3048-e3057. PubMed ID: 35276006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.
    Korvala J; Jüppner H; Mäkitie O; Sochett E; Schnabel D; Mora S; Bartels CF; Warman ML; Deraska D; Cole WG; Hartikka H; Ala-Kokko L; Männikkö M
    BMC Med Genet; 2012 Apr; 13():26. PubMed ID: 22487062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOVEL MUTATIONS IN THE WNT1, TMEM38B, P4HB, AND PLS3 GENES IN FOUR UNRELATED CHINESE FAMILIES WITH OSTEOGENESIS IMPERFECTA.
    Cao YJ; Zhang H; Zhang ZL
    Endocr Pract; 2019 Mar; 25(3):230-241. PubMed ID: 30913006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Genetics to Clinical Implications: A Study of 675 Dutch Osteogenesis Imperfecta Patients.
    Storoni S; Verdonk SJE; Zhytnik L; Pals G; Treurniet S; Elting MW; Sakkers RJB; van den Aardweg JG; Eekhoff EMW; Micha D
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-Linked Osteogenesis Imperfecta Possibly Caused by a Novel Variant in
    Brlek P; Antičević D; Molnar V; Matišić V; Robinson K; Aradhya S; Krpan D; Primorac D
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.
    Wesseling-Perry K; Mäkitie RE; Välimäki VV; Laine T; Laine CM; Välimäki MJ; Pereira RC; Mäkitie O
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2340-2348. PubMed ID: 28379384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in WNT1 cause different forms of bone fragility.
    Keupp K; Beleggia F; Kayserili H; Barnes AM; Steiner M; Semler O; Fischer B; Yigit G; Janda CY; Becker J; Breer S; Altunoglu U; Grünhagen J; Krawitz P; Hecht J; Schinke T; Makareeva E; Lausch E; Cankaya T; Caparrós-Martín JA; Lapunzina P; Temtamy S; Aglan M; Zabel B; Eysel P; Koerber F; Leikin S; Garcia KC; Netzer C; Schönau E; Ruiz-Perez VL; Mundlos S; Amling M; Kornak U; Marini J; Wollnik B
    Am J Hum Genet; 2013 Apr; 92(4):565-74. PubMed ID: 23499309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot Study.
    Välimäki VV; Mäkitie O; Pereira R; Laine C; Wesseling-Perry K; Määttä J; Kirjavainen M; Viljakainen H; Välimäki MJ
    J Clin Endocrinol Metab; 2017 Feb; 102(2):535-544. PubMed ID: 27732335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omics analyses reveal aberrant differentiation trajectory with WNT1 loss-of-function in type XV osteogenesis imperfecta.
    Tan Z; Chen P; Zhang J; Shek HT; Li Z; Zhou X; Zhou Y; Yin S; Dong L; Feng L; Wong JSH; Gao B; To MKT
    J Bone Miner Res; 2024 Sep; 39(9):1253-1267. PubMed ID: 39126373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23.
    Mäkitie RE; Kämpe A; Costantini A; Alm JJ; Magnusson P; Mäkitie O
    J Bone Miner Res; 2020 May; 35(5):901-912. PubMed ID: 31968132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype analysis of a rare type of osteogenesis imperfecta in four Chinese families with WNT1 mutations.
    Liu Y; Song L; Ma D; Lv F; Xu X; Wang J; Xia W; Jiang Y; Wang O; Song Y; Xing X; Asan ; Li M
    Clin Chim Acta; 2016 Oct; 461():172-80. PubMed ID: 27450065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis.
    Peris P; Monegal A; Mäkitie RE; Guañabens N; González-Roca E
    Osteoporos Int; 2023 Feb; 34(2):405-411. PubMed ID: 36396825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Homozygous LRP5 Mutations in Mexican Patients with Osteoporosis-Pseudoglioma Syndrome.
    Astiazarán MC; Cervantes-Sodi M; Rebolledo-Enríquez E; Chacón-Camacho O; Villegas V; Zenteno JC
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):742-746. PubMed ID: 29131652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The swaying mouse as a model of osteogenesis imperfecta caused by WNT1 mutations.
    Joeng KS; Lee YC; Jiang MM; Bertin TK; Chen Y; Abraham AM; Ding H; Bi X; Ambrose CG; Lee BH
    Hum Mol Genet; 2014 Aug; 23(15):4035-42. PubMed ID: 24634143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-Onset Osteoporosis: Molecular Analysis in Large Cohort and Focus on the PLS3 Gene.
    Mancini M; Chapurlat R; Isidor B; Desjonqueres M; Couture G; Guggenbuhl P; Coutant R; El Chehadeh S; Fradin M; Frazier A; Goldenberg A; Guillot P; Koumakis E; Mehsen-Cêtre N; Rossi M; Schaefer É; Sigaudy S; Porquet-Bordes V; Fontanges É; Letard P; Edouard T; Javier RM; Cohen-Solal M; Funck-Brentano T; Collet C
    Calcif Tissue Int; 2024 Nov; 115(5):591-598. PubMed ID: 39316135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteogenesis imperfecta in 140 Turkish families: Molecular spectrum and, comparison of long-term clinical outcome of those with COL1A1/A2 and biallelic variants.
    Tüysüz B; Elkanova L; Uludağ Alkaya D; Güleç Ç; Toksoy G; Güneş N; Yazan H; Bayhan AI; Yıldırım T; Yeşil G; Uyguner ZO
    Bone; 2022 Feb; 155():116293. PubMed ID: 34902613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosis.
    Loid P; Hauta-Alus H; Mäkitie O; Magnusson P; Mäkitie RE
    Front Endocrinol (Lausanne); 2022; 13():954730. PubMed ID: 36157448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta.
    Pyott SM; Tran TT; Leistritz DF; Pepin MG; Mendelsohn NJ; Temme RT; Fernandez BA; Elsayed SM; Elsobky E; Verma I; Nair S; Turner EH; Smith JD; Jarvik GP; Byers PH
    Am J Hum Genet; 2013 Apr; 92(4):590-7. PubMed ID: 23499310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal characteristics associated with homozygous and heterozygous WNT1 mutations.
    Palomo T; Al-Jallad H; Moffatt P; Glorieux FH; Lentle B; Roschger P; Klaushofer K; Rauch F
    Bone; 2014 Oct; 67():63-70. PubMed ID: 25010833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.